Comment
. 2003 May 10;361(9369):1652; author reply 1652-3.
doi: 10.1016/S0140-6736(03)13274-6.
Combined salmeterol and fluticasone for COPD
- PMID: 12747904
- DOI: 10.1016/S0140-6736(03)13274-6
Item in Clipboard
Comment
Combined salmeterol and fluticasone for COPD
Lancet.
.
No abstract available
Comment on
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2. Lancet. 2003. PMID: 12583942 Clinical Trial.
Similar articles
-
Combined salmeterol and fluticasone for COPD.Lancet. 2003 May 10;361(9369):1651; author reply 1652-3. doi: 10.1016/S0140-6736(03)13272-2. Lancet. 2003. PMID: 12747901 No abstract available.
-
Combined salmeterol and fluticasone for COPD.Lancet. 2003 May 10;361(9369):1651; author reply 1652-3. doi: 10.1016/S0140-6736(03)13271-0. Lancet. 2003. PMID: 12747902 No abstract available.
-
Fluticasone/salmeterol: labeling change.Prescrire Int. 2008 Dec;17(98):229. Prescrire Int. 2008. PMID: 19418648
-
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.Am J Med. 2006 Oct;119(10 Suppl 1):63-72. doi: 10.1016/j.amjmed.2006.08.009. Am J Med. 2006. PMID: 16996901 Review.
-
Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease.Expert Opin Pharmacother. 2013 Oct;14(14):1993-2002. doi: 10.1517/14656566.2013.823949. Epub 2013 Jul 31. Expert Opin Pharmacother. 2013. PMID: 23898819 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
